Full history for every metric is available with a Kvantra account

Stock profile

NuVasive, Inc. (NUVA)

Country: United States of AmericaSector: HealthcareIndustry: Medical - DevicesExchange: NASDAQ

Delisted · last close 8 Sep 2023

Current price
39.75 USD0.00%
Last close 8 Sep 2023
Benchmarks

Key financial summary

Financials in USD
201720182019202020212022TTM
Total revenue$m1,0301,1021,1681,0511,1391,2021,226
Operating profit$m6582
Net profit$m831265-37-644028
EPS reported$0.760.50
Operating cashflow per share$2.952.95
Capex per share$2.432.43
FCF per share$0.520.52
Free cash flow$m30-3
Net debt$m757715
Book value equity$m869893
Book value per share$15.1516.87
Number of sharesm57.3652.91
DPS (TTM paid)$0.000.00

Financial summary

Financials in USD
201720182019202020212022TTM
Value
P/E TTMx54.26-
P/B LTMx2.722.34
P/S LTMx1.971.70
P/FCF LTMx79.67-626.27
EV/EBITDA LTMx21.0017.08
EV/Sales LTMx2.602.28
Earnings Yield LTM%1.84%1.77%
FCF Yield%1.26%-0.16%
Quality
ROE%4.65%4.86%
ROIC%2.54%2.54%
Operating margin%5.39%5.39%
Gross margin%72.00%72.00%
FCF/Sales%2.47%2.47%
Growth and momentum
EPS Growth YoY%--
Sales Growth YoY%+5.53%+4.44%
Net Income Growth YoY%--
FCF Growth%-57.41%-
Operating Profit Growth%+106.33%+178.11%
Dividend and capital structure
Dividend Yield%0.00%0.00%
Dividend Growth%0.00%0.00%
Payout Ratio%0.00%0.00%
FCF/Debtx0.03-0.00
Net Debt/EBITDAx5.095.09
EBIT/Net interestx3.723.72
Net debt/market cap%32.02%34.29%
Net debt/Equityx0.870.80
Gross debt/equityx1.161.02

Company overview

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.

WebsiteN/A
IndustryMedical - Devices
Trades inUSD

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Delisted · last close 8 Sep 2023

NuVasive, Inc. (NUVA)

NUVA · NASDAQ · Healthcare
39.75 USD0.00%
Benchmarks
Financialsin USD
20212022TTM
About

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.

IndustryMedical - Devices
Trades inUSD

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data

Sign up for Free

Unlock all fundamental data

Sign up for Free